Executive Office

She holds a law degree from the University of Barcelona and a Master’s degree in Health Policy, Planning and Financing from the London School of Economics and Political Science and the London School of Hygiene and Tropical Medicine. Her main field of interest is cross border healthcare within the EU and health data protection.

She started getting involved in patient advocacy in 2007. Since then she has collaborated with a number of patient organizations across Europe. She has worked at the leading Institute of Public Law (IDP Barcelona) and the European Commission (DG Health and Consumers). Currently she is also a legal advisor in the clinical ethics committee of the Hospital de Mollet (Barcelona).

She speaks Spanish, German, English, Catalan and French.

Ananda has lived and worked predominantly in Spain, Germany, the UK and Belgium. Currently she is based in Brussels.

She holds a bachelor degree in journalism from Universidad Complutense of Madrid and a Master’s degree in Audiovisual Communication from Universidad Antonio de Nebrija, in Madrid.

Ana worked as a journalist in health-specialized weekly newspapers and consumer health monthly magazines. She has been involved in different patient advocacy groups, first as a volunteer and later on within the communication department. Since 2014, Ana worked as PR and press consultant in the health department of an international PR agency developing communication strategies for the main pharmaceutical companies.

Ana has been involved in the elaboration of two books focused on patients with cancer as a co-writer and editorial coordinator. She speaks Spanish and English. She is currently based in Madrid.

She holds a Bachelor’s degree in Government from the London School of Economics and Political Sciences and a Master’s degree in International and European Politics from the University of Edinburgh. She also holds a Diploma in Public Relations from the Chartered Institute for Public Relations. Her main area of interest is health policy, with a specific focus on policies affecting drug development and access in European countries.

Kate previously worked for eight years in the Policy Team at Myeloma UK, where she was involved in influencing a range of policy and reimbursement decisions affecting myeloma patient access to good quality care and effective new drugs. She was involved in a number of patient and public advisory panels in the UK healthcare system, including for the Scottish Medicines Consortium, the drug approval body in Scotland.

She been involved in a wide-range of patient organisation networks, both nationally and internationally – most recently chairing the Blood Cancers Alliance, an information-sharing network of haematological cancer charities in the UK.

Kate currently lives and works in Edinburgh, Scotland.